Cargando…
miR-6086 inhibits ovarian cancer angiogenesis by downregulating the OC2/VEGFA/EGFL6 axis
miRNAs have emerged as a pivotal component of gene regulatory networks, mediating cytokines secretion, cell cycle, and differentiation regulation. However, how miRNAs collaborate with transcription factors and downstream effector proteins that determine the fate of ovarian cancer cells remains to be...
Autores principales: | Wu, Binhua, Zhang, Ligang, Yu, Yunfei, Lu, Tongyi, Zhang, Yinmei, Zhu, Wenhui, Song, Qifang, Lv, Chengding, Guo, Jiaying, Tian, Yiqiao, Deng, Ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214437/ https://www.ncbi.nlm.nih.gov/pubmed/32393810 http://dx.doi.org/10.1038/s41419-020-2501-5 |
Ejemplares similares
-
CRISPR/Cas9-Mediated OC-2 Editing Inhibits the Tumor Growth and Angiogenesis of Ovarian Cancer
por: Lu, Tongyi, et al.
Publicado: (2020) -
Knockout of EGFL6 by CRISPR/Cas9 Mediated Inhibition of Tumor Angiogenesis in Ovarian Cancer
por: Zhu, Wenhui, et al.
Publicado: (2020) -
Blockade of ONECUT2 expression in ovarian cancer inhibited tumor cell proliferation, migration, invasion and angiogenesis
por: Lu, Tongyi, et al.
Publicado: (2018) -
The Design, Characterizations, and Tumor Angiogenesis Inhibition of a Multi-Epitope Peptibody With bFGF/VEGFA
por: Zhang, Ligang, et al.
Publicado: (2020) -
Thalidomide targets EGFL6 to inhibit EGFL6/PAX6 axis-driven angiogenesis in small bowel vascular malformation
por: Tang, Chao-Tao, et al.
Publicado: (2020)